Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

1 to 1 of 1 Result
Replication for Week 48 Data for Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial
Dec 2, 2022
Ombajo, Loice Achieng, 2022, "Replication for Week 48 Data for Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial", https://doi.org/10.7910/DVN/GIEE3K, Harvard Dataverse, V1, UNF:6:nDxWIz5UO+oMBMqROvb6QA== [fileUNF]
This is week 48 dataset from an open-label, randomized, active-controlled, multi-centre non-inferiority trial conducted by University of Nairobi. The trial enrolled 791 participants ≥ 18 years old from among people receiving outpatient HIV care at four study sites in Kenya. The variables contained in this dataset are; demographics, ARV history, bod...
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.